Detalhe da pesquisa
1.
A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects.
Antimicrob Agents Chemother
; 68(1): e0109923, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059635
2.
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
Antimicrob Agents Chemother
; 68(1): e0120123, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38063399
3.
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.
Am J Respir Crit Care Med
; 207(6): 704-720, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36215036
4.
Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.
Antimicrob Agents Chemother
; 67(3): e0155022, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815858
5.
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model.
J Antimicrob Chemother
; 78(2): 397-410, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473954
6.
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study.
J Antimicrob Chemother
; 78(8): 1963-1973, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37367723
7.
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
Ther Drug Monit
; 45(2): 265-268, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994070
8.
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates.
Antimicrob Agents Chemother
; 66(5): e0214021, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389238
9.
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study.
Antimicrob Agents Chemother
; 66(8): e0014222, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862757
10.
Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill Patients.
Antimicrob Agents Chemother
; 66(6): e0218921, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575578
11.
Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.
Antimicrob Agents Chemother
; 66(7): e0041922, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762797
12.
Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.
Antimicrob Agents Chemother
; 66(1): e0214621, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780264
13.
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum ß-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model.
Antimicrob Agents Chemother
; 66(9): e0016222, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924928
14.
Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
Antimicrob Agents Chemother
; 66(1): e0137721, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633852
15.
In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation.
J Antimicrob Chemother
; 77(4): 1041-1044, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045178
16.
Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.
J Antimicrob Chemother
; 77(5): 1324-1333, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35211736
17.
Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?
J Antimicrob Chemother
; 77(8): 2227-2237, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678266
18.
Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum ß-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model.
J Antimicrob Chemother
; 77(9): 2448-2455, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35724128
19.
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates.
J Antimicrob Chemother
; 77(11): 3026-3034, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031790
20.
Microsampling to support pharmacokinetic clinical studies in pediatrics.
Pediatr Res
; 91(6): 1557-1561, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023854